Cargando…
Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies
The identification and validation of biomarkers for clinical applications remains an important issue for improving diagnostics and therapy in many diseases, including prostate cancer. Gene expression profiles are routinely applied to identify diagnostic and predictive biomarkers or novel targets for...
Autores principales: | Alinezhad, Saeid, Väänänen, Riina-Minna, Mattsson, Jesse, Li, Yifeng, Tallgrén, Terhi, Tong Ochoa, Natalia, Bjartell, Anders, Åkerfelt, Malin, Taimen, Pekka, Boström, Peter J., Pettersson, Kim, Nees, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873225/ https://www.ncbi.nlm.nih.gov/pubmed/27196083 http://dx.doi.org/10.1371/journal.pone.0155901 |
Ejemplares similares
-
Correction: Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies
por: Alinezhad, Saeid, et al.
Publicado: (2016) -
Global expression of AMACR transcripts predicts risk for prostate cancer – a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate
por: Alinezhad, Saeid, et al.
Publicado: (2016) -
Altered PCA3 and TMPRSS2-ERG expression in histologically benign regions of cancerous prostates: a systematic, quantitative mRNA analysis in five prostates
por: Väänänen, Riina-Minna, et al.
Publicado: (2015) -
CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer
por: Petruk, Nataliia, et al.
Publicado: (2021) -
Segmentation of Image Data from Complex Organotypic 3D Models of Cancer Tissues with Markov Random Fields
por: Robinson, Sean, et al.
Publicado: (2015)